Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 13.71%77.29M | 41.67%156.44M | 71.75%67.97M | -31.41%110.43M | -49.96%39.58M | 34.75%161M | 10.94%68.45M | 178.00%79.08M | -15.58%12.52M | 49.74%119.49M |
| Operating income | 13.71%77.29M | 41.67%156.44M | 71.75%67.97M | -31.41%110.43M | -49.96%39.58M | 34.75%161M | 10.94%68.45M | 178.00%79.08M | -15.58%12.52M | 49.74%119.49M |
| Cost of sales | ---- | -86.43%-110.36M | ---- | 13.94%-59.2M | ---- | -35.77%-68.78M | ---- | ---- | ---- | 2.11%-50.66M |
| Operating expenses | -22.60%-50.44M | -86.43%-110.36M | -118.93%-41.14M | 13.94%-59.2M | 51.15%-18.79M | -35.77%-68.78M | -36.14%-50.52M | -99.03%-38.47M | -14.72%-11.27M | 2.11%-50.66M |
| Gross profit | 0.07%26.85M | -10.06%46.08M | 29.09%26.83M | -44.44%51.23M | -48.82%20.78M | 33.99%92.22M | -27.09%17.93M | 345.42%40.61M | -75.03%1.25M | 145.40%68.82M |
| Selling expenses | 8.76%-20.73M | 41.32%-25.9M | -16.16%-22.72M | 47.67%-44.13M | 36.17%-19.56M | -68.15%-84.34M | 18.02%-14.04M | -187.97%-30.65M | -35.52%-5.53M | -57.88%-50.16M |
| Administrative expenses | -1.71%-10.57M | -23.88%-31.14M | -15.10%-10.4M | 37.99%-25.13M | 68.57%-9.03M | 13.35%-40.53M | -11.50%-22.08M | -197.75%-28.73M | -282.62%-14.89M | -104.24%-46.78M |
| Research and development expenses | 1.17%-835.32K | ---- | 27.46%-845.2K | ---- | 5.78%-1.17M | ---- | -73.95%-2.5M | -69.65%-1.24M | ---839.99K | ---- |
| Profit from asset sales | ---- | ---- | 106.79%3.63K | ---- | ---53.42K | ---- | ---- | ---- | ---- | ---- |
| Impairment and provision | 3,140.83%307.48K | -425.05%-3.4M | -140.09%-10.11K | 151.07%1.05M | 5.38%-4.21K | -141.22%-2.05M | ---- | ---4.45K | ---- | 106.94%4.97M |
| -Other impairment is provision | 3,140.83%307.48K | -425.05%-3.4M | -140.09%-10.11K | 151.07%1.05M | 5.38%-4.21K | -141.22%-2.05M | ---- | ---4.45K | ---- | 106.94%4.97M |
| Special items of operating profit | -88.55%1.22M | -57.86%4.8M | 893.37%10.65M | 13.52%11.39M | -24.94%1.07M | -76.35%10.03M | 77.65%2.44M | 60.58%1.43M | 48.56%606.86K | -76.85%42.41M |
| Operating profit | -240.52%-4.42M | -70.57%-9.55M | 137.70%3.14M | 77.30%-5.6M | 56.06%-8.34M | -228.04%-24.67M | -44.32%-18.74M | -67.36%-18.98M | -619.78%-19.58M | -83.38%19.27M |
| Financing cost | -217.17%-1.63M | -30.23%-517K | -87.97%-514.26K | 53.18%-397K | -128.27%-273.59K | 52.86%-848K | 75.41%-233.6K | 284.42%967.72K | -76.42%-472.75K | ---1.8M |
| Adjustment items of earning before tax | -115.77%-15.73K | ---- | 281.49%99.79K | ---- | -79.57%26.16K | ---- | -97.61%904.65K | 1,228.56%128.06K | 1,316.24%144.68K | ---- |
| Earning before tax | -322.19%-6.06M | -67.90%-10.07M | 131.79%2.73M | 76.50%-6M | 51.98%-8.59M | -246.08%-25.52M | -175.80%-18.07M | -50.84%-17.88M | -568.49%-19.9M | -73.94%17.47M |
| Tax | -3.59%873.67K | ---- | --906.16K | ---- | ---- | 84.96%246K | --7.96K | ---128.64K | --7.96K | 103.06%133K |
| After-tax profit from continuing operations | -242.78%-5.19M | -67.90%-10.07M | 142.34%3.64M | 76.27%-6M | 51.96%-8.59M | -243.58%-25.27M | -175.77%-18.06M | -50.78%-17.87M | -568.22%-19.9M | -71.92%17.6M |
| Special items of earning after tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---136.6K | ---- | ---- |
| Adjustment items of earning after tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --136.6K | ---- | ---- |
| Earning after tax | -242.78%-5.19M | -67.90%-10.07M | 142.34%3.64M | 76.27%-6M | 51.96%-8.59M | -243.58%-25.27M | -175.77%-18.06M | -50.78%-17.87M | -568.22%-19.9M | -71.92%17.6M |
| Minority profit | -173.67%-35.22K | 202.44%42K | 237.82%47.81K | 67.72%-41K | 65.58%-34.69K | -323.33%-127K | -353.42%-78.88K | -197.80%-100.8K | -1,862.13%-147.77K | 97.71%-30K |
| Profit attributable to shareholders | -243.70%-5.16M | -69.76%-10.11M | 141.96%3.59M | 76.31%-5.96M | 51.88%-8.55M | -242.62%-25.14M | -175.38%-17.99M | -50.36%-17.77M | -564.94%-19.75M | -72.44%17.63M |
| Basic earnings per share | -250.00%-0.006 | -70.59%-0.0116 | 140.00%0.004 | 76.39%-0.0068 | 50.00%-0.01 | -242.57%-0.0288 | -175.82%-0.0207 | -48.15%-0.02 | -564.71%-0.0226 | -72.44%0.0202 |
| Diluted earnings per share | -250.00%-0.006 | 140.00%0.004 | 50.00%-0.01 | -175.82%-0.0207 | -0.02 | -564.71%-0.0226 | -72.44%0.0202 | |||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | CAS (2007) | CAS (2007) | IAS |
| Auditor | -- | Guocheng Certified Public Accountants Co., Ltd | -- | Guocheng Certified Public Accountants Co., Ltd | -- | Ding He Guan Chen Certified Public Accountants, ZTE Caiguanghua Certified Public Accountants (Special General Partnership) | -- | -- | -- | CCA Zhonghuan (Hong Kong) Certified Public Accountants Limited, CCA Zhonghuan Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.